Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation-Reference-Cited by-同舟云学术

Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation

Published:2014-08 Issue:8 Volume:26 Page:871-879
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Campillo Ana,Solanas Estela,Morandeira Maria J.,Castiella Tomas,Lorente Sara,Garcia-Gil Francisco Agustín,Piazuelo Elena,de Martino Alba,Serrano Maria T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.;Poon;Clin Cancer Res,2003

2. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.;Poon;J Clin Oncol,2002

3. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases.;Doanes;Biochem Biophys Res Commun,1999

4. Role of vascular endothelial growth factor in regulation of physiological angiogenesis.;Ferrara;Am J Physiol Cell Physiol,2001

5. Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy.;Gerald;Cancer Res,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EpCAM, Ki67, and ESM1 Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation;Applied Immunohistochemistry & Molecular Morphology;2023-09-04

2. Arachidonic acid metabolism CYP450 pathway is deregulated in hepatocellular carcinoma and associated with microvascular invasion;Cell Biology International;2023-09

3. The Prognostic Role of VEGFR-2 Gene Amplification in Relation to Serum AFP Levels Among Liver-Transplanted Patients with Hepatocellular Carcinoma;Journal of Current Oncology;2022-12

Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2

;Cancer Management and Research;2019-04

5. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma;Pathology - Research and Practice;2018-06